In AD, increased expression of TREM2 has been confirmed in patients [47, 57–59] and in mouse models of amyloid and tau pathology [45, 60–63] and seems to be associated with the recruitment of microglia to amyloid plaques [59, 64]. Here, MAPT is linked to Alzheimer disease.